Press Release February 10, 2010

Goodwin Procter Top Ranked in Biotechnology and Pharmaceuticals Licensing Globally and in North America

Boston, February 10, 2010 – According to the newly released BioPharm Insight Biotechnology and Pharmaceutical Licensing and M&A Legal Advisor League Tables, Goodwin Procter has one of the most active biotechnology and pharmaceuticals licensing practices of U.S.-based law firms. The firm was ranked first in licensing in both the global and North American volume tables, with 10 agreements worth at least US$534 million (some deal values were not disclosed). Goodwin Procter also ranked 5th in Europe in terms of licensing by volume.

“This is the first time we have participated in these rankings, and we are pleased that they show the growth of our practice as we have expanded nationally, particularly in California, and internationally,” said Life Sciences practice co-chair Larry Wittenberg. “It reflects our commitment to support our clients and work with them on the transactions that are crucial to their success.”

In addition to being highly ranked in licensing, Goodwin Procter was also recognized as a Top 20 firm globally for life sciences mergers and acquisitions by volume.

With 160 experienced life sciences attorneys, Goodwin Procter has one of the leading Life Sciences practices in the United States. The firm’s clients include more than 400 private and public life sciences companies, from start-ups to Fortune 100 corporations. The Life Sciences practice includes professionals with 50+ advanced degrees, including 20 PhDs in disciplines ranging from organic chemistry, molecular and cell biology, and pharmacology, to biophysics and medicine, and is led by lawyers whose practice is exclusively focused on the life sciences industry.

BioPharm Insight provides market information to life science professionals worldwide through its network of journalists and research analysts. It covers the entire drug discovery and development pipeline, approved drugs, licensing deals, pharmaceutical sales/projections and management contacts. BioPharm Insight is a wholly-owned subsidiary of the Financial Times Group.

About Goodwin Procter
Goodwin Procter LLP is one of the nation’s leading law firms with offices in Boston, Hong Kong, London, Los Angeles, New York, San Diego, San Francisco, Silicon Valley, and Washington, D.C. The firm’s core areas of practice are corporate, litigation and real estate, with specialized areas of focus that include financial services, private equity, technology, REITs and real estate capital markets, intellectual property, tax and products liability. Information may be found at www.goodwinprocter.com.